cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.14062042
title: Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden

description: Men with prostate cancer (PCa) on gonadotropin-releasing hormone agonists (GnRH) have an increased risk of cardiovascular disease (CVD) compared to men with PCa not on GnRH as well as compared with PCa-free men. Whether the addition of androgen receptor targeted (ART) drugs to GnRH further increases CVD risk, remains to be fully elucidated. We investigated risk of CVD for men with castration resistant PCa (CRPC) on GnRH plus ART; abiraterone or enzalutamide vs 5,127 and 12,079 respective matched comparator men on GnRH in Prostate Cancer data Base Sweden (PCBaSe<sup>Traject</sup>) 4.1 between 1 June 2015 and 31 December 2018. PCBaSe<sup>Traject</sup> links National Prostate Cancer Register of Sweden to other healthcare registries and demographic databases. We conducted multivariable Cox proportional hazard models adjusting for PCa risk category, Charlson comorbidity index (CCI), insulin or statin use, civil status, level of education, history of CVD events and number of CVD drugs, with any incident or fatal CVD as the outcome. 1,310 men were treated with abiraterone and 3,579 with enzalutamide. In multivariable analysis, CVD risk was increased in men on abiraterone (hazard ratio (HR): 1.19; 95% confidence interval (CI): 1.03–1.38) and in men on enzalutamide (HR: 1.10; 95% CI: 1.01–1.20). Men with a recent CVD (&lt;12 months) including both men on ART as well as comparators had a much higher probability of a new CVD vs men with no prior CVD. CVD risk was mildly increased in men with PCa on GnRH plus abiraterone or enzalutamide vs comparator men on GnRH. Residual confounding and detection bias may at least partly explain this association.
DOI: 10.6084/m9.figshare.14062042.v1
title: Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden

description: Men with prostate cancer (PCa) on gonadotropin-releasing hormone agonists (GnRH) have an increased risk of cardiovascular disease (CVD) compared to men with PCa not on GnRH as well as compared with PCa-free men. Whether the addition of androgen receptor targeted (ART) drugs to GnRH further increases CVD risk, remains to be fully elucidated. We investigated risk of CVD for men with castration resistant PCa (CRPC) on GnRH plus ART; abiraterone or enzalutamide vs 5,127 and 12,079 respective matched comparator men on GnRH in Prostate Cancer data Base Sweden (PCBaSe<sup>Traject</sup>) 4.1 between 1 June 2015 and 31 December 2018. PCBaSe<sup>Traject</sup> links National Prostate Cancer Register of Sweden to other healthcare registries and demographic databases. We conducted multivariable Cox proportional hazard models adjusting for PCa risk category, Charlson comorbidity index (CCI), insulin or statin use, civil status, level of education, history of CVD events and number of CVD drugs, with any incident or fatal CVD as the outcome. 1,310 men were treated with abiraterone and 3,579 with enzalutamide. In multivariable analysis, CVD risk was increased in men on abiraterone (hazard ratio (HR): 1.19; 95% confidence interval (CI): 1.03–1.38) and in men on enzalutamide (HR: 1.10; 95% CI: 1.01–1.20). Men with a recent CVD (&lt;12 months) including both men on ART as well as comparators had a much higher probability of a new CVD vs men with no prior CVD. CVD risk was mildly increased in men with PCa on GnRH plus abiraterone or enzalutamide vs comparator men on GnRH. Residual confounding and detection bias may at least partly explain this association.
DOI: 10.6084/m9.figshare.13651548
title: Prognostic role of TLR4 and TLR2 in hepatocellular carcinoma

description: Prognostic role of TLR4 and TLR2 in hepatocellular carcinoma
DOI: 10.6084/m9.figshare.13068262
title: Management of low-grade cervical cytology in young women. Cohort study from Denmark

description: Cytology findings of atypical squamous cells of unknown significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL) are common among women under 30, but evidence on best management strategy is insufficient. We therefore investigated how different management strategies used in Denmark influenced biopsy rates and detection of cervical intraepithelial neoplasia (CIN). Register-based cohort study including Danish women aged less than 30 years and born 1980–95, with ASCUS/LSIL as their first abnormal cervical cytology in 2008–16. Rates and relative risks (RR) of biopsy and detection of CIN3+, CIN2 and 19,946 women with ASCUS and 19,825 with LSIL were included in the study of whom 92% had adequate information about follow-up. Among women referred directly to biopsy, CIN3+ was detected among 21%, CIN2 in 17%, while 62% had The choice of management strategy influences both the detection rate for severe lesions (CIN3+) and the proportion of women followed up for potentially insignificant findings.
DOI: 10.6084/m9.figshare.13489433.v1
title: Impact of time to treatment initiation for patients with oral cavity squamous cell carcinoma: a population-based, retrospective study

description: The increasing incidence of oral cavity squamous cell carcinoma (OSCC) is challenging the capacity to treat patients efficiently. The aim of this study was to evaluate the impact of time to treatment initiation (TTI) on overall survival (OS) and recurrence free survival (RFS) for patients with primary OSCC. All patients with primary OSCC treated with curative intent at Rigshospitalet in the period 2000–2014 with known date of diagnosis and treatment initiation were included. Correlation analyses between TTI and Charlson comorbidity index (CCI), UICC stage, and year of diagnosis were performed in addition to uni- and multivariate Cox proportional hazard regression analyses. Further, interaction analysis of TTI and UICC stage were conducted. Eight hundred and sixty-two patients (64% men) with a median age at diagnosis of 62 years (range: 28–95 years) were included. The median TTI was 31 days (range: 2–137 days). Correlation analyses showed correlations between TTI and CCI, TTI and UICC stage, and TTI and year of diagnosis (rho = −0.10, <i>p</i>-value = p-value = p-value = Survival of OSCC patients decreased with increasing TTI, yet not statistically significant in multivariate analysis. There was no difference in the effect of TTI between patients diagnosed in low or advanced stages.
DOI: 10.6084/m9.figshare.13068262.v1
title: Management of low-grade cervical cytology in young women. Cohort study from Denmark

description: Cytology findings of atypical squamous cells of unknown significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL) are common among women under 30, but evidence on best management strategy is insufficient. We therefore investigated how different management strategies used in Denmark influenced biopsy rates and detection of cervical intraepithelial neoplasia (CIN). Register-based cohort study including Danish women aged less than 30 years and born 1980–95, with ASCUS/LSIL as their first abnormal cervical cytology in 2008–16. Rates and relative risks (RR) of biopsy and detection of CIN3+, CIN2 and 19,946 women with ASCUS and 19,825 with LSIL were included in the study of whom 92% had adequate information about follow-up. Among women referred directly to biopsy, CIN3+ was detected among 21%, CIN2 in 17%, while 62% had The choice of management strategy influences both the detection rate for severe lesions (CIN3+) and the proportion of women followed up for potentially insignificant findings.
DOI: 10.6084/m9.figshare.13489432
title: Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)

description: Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)
DOI: 10.6084/m9.figshare.13677523.v1
title: Immune cell score, PD-L1 expression and prognosis in esophageal cancer

description: Immune cell score, PD-L1 expression and prognosis in esophageal cancer
DOI: 10.6084/m9.figshare.13489433
title: Impact of time to treatment initiation for patients with oral cavity squamous cell carcinoma: a population-based, retrospective study

description: The increasing incidence of oral cavity squamous cell carcinoma (OSCC) is challenging the capacity to treat patients efficiently. The aim of this study was to evaluate the impact of time to treatment initiation (TTI) on overall survival (OS) and recurrence free survival (RFS) for patients with primary OSCC. All patients with primary OSCC treated with curative intent at Rigshospitalet in the period 2000–2014 with known date of diagnosis and treatment initiation were included. Correlation analyses between TTI and Charlson comorbidity index (CCI), UICC stage, and year of diagnosis were performed in addition to uni- and multivariate Cox proportional hazard regression analyses. Further, interaction analysis of TTI and UICC stage were conducted. Eight hundred and sixty-two patients (64% men) with a median age at diagnosis of 62 years (range: 28–95 years) were included. The median TTI was 31 days (range: 2–137 days). Correlation analyses showed correlations between TTI and CCI, TTI and UICC stage, and TTI and year of diagnosis (rho = −0.10, <i>p</i>-value = p-value = p-value = Survival of OSCC patients decreased with increasing TTI, yet not statistically significant in multivariate analysis. There was no difference in the effect of TTI between patients diagnosed in low or advanced stages.
DOI: 10.6084/m9.figshare.13489432.v1
title: Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)

description: Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)
DOI: 10.5281/zenodo.4646955
title: Low-mass stars MESA files

description: These files were used to run main-sequence models of low-mass stars.
DOI: 10.5281/zenodo.4646954
title: Low-mass stars MESA files

description: These files were used to run main-sequence models of low-mass stars.
DOI: 10.5281/zenodo.4646900
title: The cost and the value of treatment of medication overuse headache in Italy: a longitudinal study based on patient-derived data

description: dataset related to the main results of the MOH-Cost project, aimed to estimate the annual cost of Medication Overuse Headache in Italy
description: Study supported by Italian Ministry of Health
DOI: 10.5281/zenodo.4646899
title: The cost and the value of treatment of medication overuse headache in Italy: a longitudinal study based on patient-derived data

description: dataset related to the main results of the MOH-Cost project, aimed to estimate the annual cost of Medication Overuse Headache in Italy
description: Study supported by Italian Ministry of Health
DOI: 10.5281/zenodo.4646978
title: Data for "The effect of nest temperature on growth and survival in juvenile Great Tits Parus major"

description: Two datasets including the demographic and growth data collected for the years 2017 and 2018 in the framework of the SBU Bird Project
DOI: 10.5281/zenodo.4646977
title: Data for "The effect of nest temperature on growth and survival in juvenile Great Tits Parus major"

description: Two datasets including the demographic and growth data collected for the years 2017 and 2018 in the framework of the SBU Bird Project
DOI: 10.6084/m9.figshare.14339417
title: Supplementary Material for: Kidney Injury Molecule-1 and Periostin Urinary Excretion and Tissue Expression Levels and Association with Glomerular Disease Outcomes

description: <b><i>Introductions:</i></b> Kidney injury molecule-1 (KIM-1) and periostin (POSTN) are proximal and distal tubule injury biomarkers. We tested whether baseline urine KIM-1/Cr (uKIM-1/Cr) and/or uPOSTN/Cr correlated with disease severity or improved a remission prediction model. <b><i>Methods:</i></b> Baseline uKIM-1/Cr and uPOSTN/Cr were measured on spot urine samples from immunosuppression-free patients enrolled in Nephrotic Syndrome Study Network until December 15, 2014. Urine protein/Cr (UPCR) and albumin/Cr (UACR) were measured at baseline, 4 months, and until last follow-up. Glomerular and tubulointerstitial (TI) expression arrays were analyzed from a baseline research renal biopsy core collected during a clinically indicated biopsy. Renal diagnoses were centrally confirmed, sections scanned, and measured morphometrically. Correlations between baseline uKIM-1/Cr and uPOSTN/Cr and UPCR, UACR, histopathologic features, glomerular and TI KIM-1 and POSTN expression levels, and renal outcomes were assessed. <b><i>Results:</i></b> Baseline uKIM-1/cr correlated with UPCR and UACR and were associated with complete remission (CR) after adjustment for proteinuria, histopathologic diagnosis, and treatment. Baseline uKIM-1/Cr also correlated with degree of foot process effacement and acute tubular injury. Glomerular and TI KIM-1 expression levels correlated with UPCR and UACR. Higher TI KIM-1 expression levels correlated with interstitial fibrosis, tubular atrophy, and global glomerulosclerosis, while glomerular KIM-1 expression correlated with time to remission. Findings for POSTN were of lesser statistical strength. <b><i>Discussion/Conclusion:</i></b> Lower baseline uKIM-1/Cr values were associated with more rapid time to CR after adjusting for proteinuria, histopathologic diagnosis, and treatment. Increased TI KIM-1 expression levels in proteinuric states were associated with chronic morphological injury; lower glomerular expression levels were associated with a greater potential for proteinuria reversibility.
DOI: 10.5281/zenodo.4646092
title: Database of water ice-bearing permanently shaded regions in the lunar south polar region

description: Database of water ice-bearing permanently shaded regions in the lunar south polar region, as described in Lemelin et al. (2021) <em>Framework for Coordinated Efforts in the Exploration of Volatiles in the South Polar Region of the Moon</em>, Planetary Science Journal. This database includes information that could be used to help identify the best location for missions designed to validate the detections of water ice at the surface in the south polar region and extend those observations to determine the lateral and vertical extent of that ice. The database is available in two formats: (1) an Excel spreadsheet, (2) an ArcGIS shapefile.
description: {"references": ["Lemelin et al. (2021)\u00a0Framework for Coordinated Efforts in the Exploration of Volatiles in the South Polar Region of the Moon, Planetary Science Journal."]}
DOI: 10.5281/zenodo.4646091
title: Database of water ice-bearing permanently shaded regions in the lunar south polar region

description: Database of water ice-bearing permanently shaded regions in the lunar south polar region, as described in Lemelin et al. (2021) <em>Framework for Coordinated Efforts in the Exploration of Volatiles in the South Polar Region of the Moon</em>, Planetary Science Journal. This database includes information that could be used to help identify the best location for missions designed to validate the detections of water ice at the surface in the south polar region and extend those observations to determine the lateral and vertical extent of that ice. The database is available in two formats: (1) an Excel spreadsheet, (2) an ArcGIS shapefile.
description: {"references": ["Lemelin et al. (2021)\u00a0Framework for Coordinated Efforts in the Exploration of Volatiles in the South Polar Region of the Moon, Planetary Science Journal."]}
DOI: 10.6084/m9.figshare.14339555
title: Nutrition values raw data

description: This is a collection of data from 3 different SNF regarding daily intake at different meals and meal times. Data was collected from meal cards at each facility. The companies utilized to supply the food were comparable in price and quality. The nutritional value of the meals were calculated based on the USDA food composition database; with reference to the supply company and were compared to national recommendations.
DOI: 10.5281/zenodo.4644244
title: Corpus of Early English Correspondence Extension Sampler part 1 (CEECES 1)

description: The Corpus of Early English Correspondence Extension Sampler part 1 (CEECES 1) is the first public release of the 18th-century part of the Corpora of Early English Correspondence (CEEC-400). The full CEECES will be released in 3 parts over the course of 2021. See the accompanying manual for more. See https://varieng.helsinki.fi/CoRD/corpora/CEEC/ for more on the CEEC-400. Citation: CEECES 1 = <em>Corpus of Early English Correspondence Extension Sampler</em> part 1. Compiled by Terttu Nevalainen, Helena Raumolin-Brunberg, Samuli Kaislaniemi, Mikko Laitinen, Minna Nevala, Arja Nurmi, Minna Palander-Collin, Tanja Säily and Anni Sairio at the Department of Languages, University of Helsinki. XML conversion and encoding by Lassi Saario. <strong>ETA</strong> Some of the hyperlinks in the manual don't work: use the link above instead.
DOI: 10.5517/ccdc.csd.cc23m06z
title: CCDC 1954680: Experimental Crystal Structure Determination

description: Related Article: Jongho So, Seji Kim, Kyung-Bin Cho, Yunho Lee|2021|Chem.Commun.|57|3219|doi:10.1039/D0CC08012H
DOI: 10.5517/ccdc.csd.cc23m070
title: CCDC 1954681: Experimental Crystal Structure Determination

description: Related Article: Jongho So, Seji Kim, Kyung-Bin Cho, Yunho Lee|2021|Chem.Commun.|57|3219|doi:10.1039/D0CC08012H
DOI: 10.5517/ccdc.csd.cc23m081
title: CCDC 1954682: Experimental Crystal Structure Determination

description: Related Article: Jongho So, Seji Kim, Kyung-Bin Cho, Yunho Lee|2021|Chem.Commun.|57|3219|doi:10.1039/D0CC08012H
DOI: 10.5517/ccdc.csd.cc23m0b3
title: CCDC 1954684: Experimental Crystal Structure Determination

description: Related Article: Jongho So, Seji Kim, Kyung-Bin Cho, Yunho Lee|2021|Chem.Commun.|57|3219|doi:10.1039/D0CC08012H
DOI: 10.5517/ccdc.csd.cc23m0c4
title: CCDC 1954685: Experimental Crystal Structure Determination

description: Related Article: Jongho So, Seji Kim, Kyung-Bin Cho, Yunho Lee|2021|Chem.Commun.|57|3219|doi:10.1039/D0CC08012H
DOI: 10.5517/ccdc.csd.cc23m0d5
title: CCDC 1954686: Experimental Crystal Structure Determination

description: Related Article: Jongho So, Seji Kim, Kyung-Bin Cho, Yunho Lee|2021|Chem.Commun.|57|3219|doi:10.1039/D0CC08012H
DOI: 10.5517/ccdc.csd.cc23ps7v
title: CCDC 1957347: Experimental Crystal Structure Determination

description: Related Article: Meng-Yang Chang, Min-Chen Tsai, Chun-Yi Lin|2021|RSC Advances|11|11655|doi:10.1039/D1RA00534K
DOI: 10.5517/ccdc.csd.cc25dztd
title: CCDC 2008484: Experimental Crystal Structure Determination

description: Related Article: Madhumita Chatterjee, Sudipta Mondal, Arijit Singha Hazari, Stanislav Záliš, Wolfgang Kaim, Goutam Kumar Lahiri|2021|Dalton Trans.|50|4191|doi:10.1039/D1DT00282A
DOI: 10.5517/ccdc.csd.cc25dzvf
title: CCDC 2008485: Experimental Crystal Structure Determination

description: Related Article: Madhumita Chatterjee, Sudipta Mondal, Arijit Singha Hazari, Stanislav Záliš, Wolfgang Kaim, Goutam Kumar Lahiri|2021|Dalton Trans.|50|4191|doi:10.1039/D1DT00282A
DOI: 10.5517/ccdc.csd.cc25dzwg
title: CCDC 2008486: Experimental Crystal Structure Determination

description: Related Article: Madhumita Chatterjee, Sudipta Mondal, Arijit Singha Hazari, Stanislav Záliš, Wolfgang Kaim, Goutam Kumar Lahiri|2021|Dalton Trans.|50|4191|doi:10.1039/D1DT00282A
DOI: 10.5517/ccdc.csd.cc25dzxh
title: CCDC 2008487: Experimental Crystal Structure Determination

description: Related Article: Madhumita Chatterjee, Sudipta Mondal, Arijit Singha Hazari, Stanislav Záliš, Wolfgang Kaim, Goutam Kumar Lahiri|2021|Dalton Trans.|50|4191|doi:10.1039/D1DT00282A
DOI: 10.5517/ccdc.csd.cc25qxd7
title: CCDC 2018019: Experimental Crystal Structure Determination

description: Related Article: Kevin Blann, Annette Bollmann, Gavin M. Brown, John T. Dixon, Mark R. J. Elsegood, Christopher R. Raw, Martin B. Smith, Kenny Tenza, J. Alexander Willemse, Pumza Zweni|2021|Dalton Trans.|50|4345|doi:10.1039/D1DT00287B
DOI: 10.5517/ccdc.csd.cc25qxf8
title: CCDC 2018020: Experimental Crystal Structure Determination

description: Related Article: Kevin Blann, Annette Bollmann, Gavin M. Brown, John T. Dixon, Mark R. J. Elsegood, Christopher R. Raw, Martin B. Smith, Kenny Tenza, J. Alexander Willemse, Pumza Zweni|2021|Dalton Trans.|50|4345|doi:10.1039/D1DT00287B
DOI: 10.5517/ccdc.csd.cc25qxg9
title: CCDC 2018021: Experimental Crystal Structure Determination

description: Related Article: Kevin Blann, Annette Bollmann, Gavin M. Brown, John T. Dixon, Mark R. J. Elsegood, Christopher R. Raw, Martin B. Smith, Kenny Tenza, J. Alexander Willemse, Pumza Zweni|2021|Dalton Trans.|50|4345|doi:10.1039/D1DT00287B
DOI: 10.5517/ccdc.csd.cc25qxhb
title: CCDC 2018022: Experimental Crystal Structure Determination

description: Related Article: Kevin Blann, Annette Bollmann, Gavin M. Brown, John T. Dixon, Mark R. J. Elsegood, Christopher R. Raw, Martin B. Smith, Kenny Tenza, J. Alexander Willemse, Pumza Zweni|2021|Dalton Trans.|50|4345|doi:10.1039/D1DT00287B
DOI: 10.5517/ccdc.csd.cc25y84k
title: CCDC 2024118: Experimental Crystal Structure Determination

description: Related Article: Daniel G. Congrave, Bluebell H. Drummond, Victor Gray, Andrew D. Bond, Akshay Rao, Richard H. Friend, Hugo Bronstein|2021|Polym.Chem.|12|1830|doi:10.1039/D1PY00118C
DOI: 10.5517/ccdc.csd.cc260zlt
title: CCDC 2026736: Experimental Crystal Structure Determination

description: Related Article: Yan-Min Su, Bao-Qian Ji, Feng Shao, Shan-Shan Zhang, Marko Jagodič, Zvonko Jagličić, Zhi-Yong Gao, Jian-Min Dou, Di Sun|2021|Dalton Trans.|50|4355|doi:10.1039/D1DT00165E
DOI: 10.5517/ccdc.csd.cc260zmv
title: CCDC 2026737: Experimental Crystal Structure Determination

description: Related Article: Yan-Min Su, Bao-Qian Ji, Feng Shao, Shan-Shan Zhang, Marko Jagodič, Zvonko Jagličić, Zhi-Yong Gao, Jian-Min Dou, Di Sun|2021|Dalton Trans.|50|4355|doi:10.1039/D1DT00165E
DOI: 10.5517/ccdc.csd.cc260znw
title: CCDC 2026738: Experimental Crystal Structure Determination

description: Related Article: Yan-Min Su, Bao-Qian Ji, Feng Shao, Shan-Shan Zhang, Marko Jagodič, Zvonko Jagličić, Zhi-Yong Gao, Jian-Min Dou, Di Sun|2021|Dalton Trans.|50|4355|doi:10.1039/D1DT00165E
DOI: 10.5517/ccdc.csd.cc26lyb3
title: CCDC 2043995: Experimental Crystal Structure Determination

description: Related Article: Houyang Xu, Meng-Di Lin, Jun Yuan, Baiyang Zhou, Yingxiao Mu, Yanping Huo, Kelong Zhu|2021|Chem.Commun.|57|3239|doi:10.1039/D0CC07471C
DOI: 10.5517/ccdc.csd.cc26lyc4
title: CCDC 2043996: Experimental Crystal Structure Determination

description: Related Article: Houyang Xu, Meng-Di Lin, Jun Yuan, Baiyang Zhou, Yingxiao Mu, Yanping Huo, Kelong Zhu|2021|Chem.Commun.|57|3239|doi:10.1039/D0CC07471C
DOI: 10.5517/ccdc.csd.cc23pdcl
title: CCDC 1956979: Experimental Crystal Structure Determination

description: Related Article: Anton V. Savchenkov, Andrei S. Uhanov, Mikhail S. Grigoriev, Aleksandr M. Fedoseev, Denis V. Pushkin, Larisa B. Serezhkina, Viktor N. Serezhkin|2021|Dalton Trans.|50|4210|doi:10.1039/D0DT04083E
DOI: 10.5517/ccdc.csd.cc23pddm
title: CCDC 1956980: Experimental Crystal Structure Determination

description: Related Article: Anton V. Savchenkov, Andrei S. Uhanov, Mikhail S. Grigoriev, Aleksandr M. Fedoseev, Denis V. Pushkin, Larisa B. Serezhkina, Viktor N. Serezhkin|2021|Dalton Trans.|50|4210|doi:10.1039/D0DT04083E
DOI: 10.5517/ccdc.csd.cc23pdfn
title: CCDC 1956981: Experimental Crystal Structure Determination

description: Related Article: Anton V. Savchenkov, Andrei S. Uhanov, Mikhail S. Grigoriev, Aleksandr M. Fedoseev, Denis V. Pushkin, Larisa B. Serezhkina, Viktor N. Serezhkin|2021|Dalton Trans.|50|4210|doi:10.1039/D0DT04083E